Literature DB >> 28017207

The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability.

Andreas Charidimou1, Anne Schmitt2, Duncan Wilson3, Yusuke Yakushiji3, Simone M Gregoire3, Zoe Fox4, Hans R Jäger5, David J Werring6.   

Abstract

PURPOSE: The causes, risk factors and prognosis of spontaneous intracerebral haemorrhage (ICH) are partly determined by anatomical location (specifically, lobar vs. non-lobar (deep and infratentorial) regions). We systematically developed a rating instrument to reliably classify ICH location.
METHODS: We used a two-stage iterative Delphi-style method for instrument development. The resultant Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS) was validated on CT and MRI scans from a cohort of consecutive patients with acute spontaneous symptomatic ICH by three independent raters. We tested interrater and intrarater reliability using kappa statistics.
RESULTS: Our validation cohort included 227 patients (58% male; median age: 72.4 (IQR: 67.1-74.6)). The interrater reliability for the main analyses (i.e. including any lobar ICH; all deep and infratentorial anatomical categories (lentiform, caudate thalamus; brainstem; cerebellum); and uncertain location) was excellent (all kappa values>0.80) both in pair-wise between-rater comparisons and across all raters. The intrarater reliability was substantial to almost perfect (k=0.83; 95%CI: 0.77-0.88 and k=0.95; 95%CI: 0.92-0.96 respectively). All kappa statistics remained consistent for individual cerebral lobar regions.
CONCLUSIONS: The CHARTS instrument can be used to reliably and comprehensively map the anatomical location of spontaneous ICH, and may be helpful for studying important questions regarding causes, risk factors, prognosis, and for stratification in clinical trials.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CT; Cerebral amyloid angiopathy; Intracerebral haemorrhage; MRI; Stroke

Mesh:

Year:  2016        PMID: 28017207     DOI: 10.1016/j.jns.2016.11.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

Review 1.  Cognitive impairment before and after intracerebral haemorrhage: a systematic review.

Authors:  Claire Donnellan; David Werring
Journal:  Neurol Sci       Date:  2019-12-04       Impact factor: 3.307

2.  APOE and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Hemorrhage.

Authors:  Isabel Charlotte Hostettler; David Seiffge; Andrew Wong; Gareth Ambler; Duncan Wilson; Clare Shakeshaft; Gargi Banerjee; Nikhil Sharma; Hans Rolf Jäger; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Y H Lip; Martin M Brown; Keith Muir; Henry Houlden; David J Werring
Journal:  Neurology       Date:  2022-07-08       Impact factor: 11.800

3.  Higher Cerebral Small Vessel Disease Burden in Patients With Small Intracerebral Hemorrhage.

Authors:  Zi-Jie Wang; Rui Zhao; Xiao Hu; Wen-Song Yang; Lan Deng; Xin-Ni Lv; Zuo-Qiao Li; Jing Cheng; Ming-Jun Pu; Zhou-Ping Tang; Guo-Feng Wu; Li-Bo Zhao; Peng Xie; Qi Li
Journal:  Front Neurosci       Date:  2022-05-12       Impact factor: 5.152

4.  Cortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI study.

Authors:  Thanakit Pongpitakmetha; Panagiotis Fotiadis; Marco Pasi; Gregoire Boulouis; Li Xiong; Andrew D Warren; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Andreas Charidimou
Journal:  Neurology       Date:  2020-04-13       Impact factor: 9.910

5.  Developing an algorithm to identify patients with intracerebral haemorrhage secondary to a macrovascular cause.

Authors:  Duncan Wilson; Ayokunle Ogungbemi; Gareth Ambler; Ifan Jones; David J Werring; Hans R Jäger
Journal:  Eur Stroke J       Date:  2017-09-19

6.  Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.

Authors:  Isabel Charlotte Hostettler; Matthew J Morton; Gareth Ambler; Nabila Kazmi; Tom Gaunt; Duncan Wilson; Clare Shakeshaft; H R Jäger; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Lip; Martin M Brown; Keith Muir; Henry Houlden; Diederik O Bulters; Ian Galea; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-01-10       Impact factor: 10.154

7.  Clinical usefulness of Edinburgh CT criteria in patients with lobar intracerebral hemorrhage.

Authors:  Raffaele Ornello; Enrico Colangeli; Emanuele Tommasino; Cindy Tiseo; Giulia Perrotta; Ciro Scarpato; Martina Gentile; Leondino Mammarella; Carmine Marini; Francesca Pistoia; Alessandra Splendiani; Simona Sacco
Journal:  Eur Stroke J       Date:  2020-11-25

8.  Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.

Authors:  Linxin Li; Michael T C Poon; Neshika E Samarasekera; Luke A Perry; Tom J Moullaali; Mark A Rodrigues; James J M Loan; Jacqueline Stephen; Christine Lerpiniere; Maria A Tuna; Sergei A Gutnikov; Wilhelm Kuker; Louise E Silver; Rustam Al-Shahi Salman; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2021-06       Impact factor: 59.935

9.  Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants.

Authors:  David J Seiffge; Duncan Wilson; Gareth Ambler; Gargi Banerjee; Isabel Charlotte Hostettler; Henry Houlden; Clare Shakeshaft; Hannah Cohen; Tarek A Yousry; Rustam Al-Shahi Salman; Gregory Lip; Martin M Brown; Keith Muir; H R Jäger; David J Werring
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-19       Impact factor: 10.154

10.  The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.

Authors:  Mark A Rodrigues; Neshika Samarasekera; Christine Lerpiniere; Catherine Humphreys; Mark O McCarron; Philip M White; James A R Nicoll; Cathie L M Sudlow; Charlotte Cordonnier; Joanna M Wardlaw; Colin Smith; Rustam Al-Shahi Salman
Journal:  Lancet Neurol       Date:  2018-01-10       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.